Despite rapid advances in automation and AI, I believe humans will remain central to manufacturing success in 2026.

As AI continues to evolve, its capacity to innovate and optimize will further solidify its role as a cornerstone of modern ...

Digital Intelligence offers a practical framework for reducing decision latency by connecting industrial data, enterprise systems and human expertise into faster operational feedback loops.

The infusion of technology into the medical field yields groundbreaking and life-saving medical devices, which, in turn, presents new considerations for manufacturers due to device development's ...

Manufacturing is getting a lot more attention in the news recently. While globalization has pushed the availability of goods around the world and lowered their cost in significant ways over these past ...

Processing automation is useful for beverage formulators to increase efficiency while also meeting consumer and beverage ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

The advanced air mobility (AAM) market is gaining traction to transform the transportation of goods and people. While OEMs have focused on design and certification, supply chains have been left to ...

Lyell Immunopharma will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program. As part of the collaboration, the ...

PLEASANTON, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today ...

Collaboration with Stanford Medicine establishes a platform manufacturing process and analytics designed to support gene-edited hematopoietic stem cell therapies for HIV and more than 19 rare diseases ...

Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...